Alto Neuroscience Inc (ANRO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
3 |
$3,567,247 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 11 Jul 2024 |
SAVITZ ADAM |
CHIEF MEDICAL OFFICER |
10 Jul 2024 |
2,931 |
13.22 |
38,748 |
| 11 Jul 2024 |
SAVITZ ADAM |
CHIEF MEDICAL OFFICER |
09 Jul 2024 |
1,388 |
13.15 |
18,252 |
| 11 Jul 2024 |
SAVITZ ADAM |
CHIEF MEDICAL OFFICER |
09 Jul 2024 |
10,681 |
12.53 |
133,833 |
| 01 Apr 2024 |
SMITH NICHOLAS CONRAD |
CHIEF FINANCIAL OFFICER |
28 Mar 2024 |
1,600 |
15.80 |
25,280 |
| 01 Apr 2024 |
SMITH NICHOLAS CONRAD |
CHIEF FINANCIAL OFFICER |
28 Mar 2024 |
4,550 |
16.56 |
75,348 |
| 08 Feb 2024 |
ALPHA WAVE GLOBAL, LP |
10% |
06 Feb 2024 |
600,000 |
16.00 |
9,600,000 |
| 07 Feb 2024 |
SMITH NICHOLAS CONRAD |
CHIEF FINANCIAL OFFICER |
06 Feb 2024 |
1,563 |
16.00 |
25,008 |
| 07 Feb 2024 |
SAVITZ ADAM |
CHIEF MEDICAL OFFICER |
06 Feb 2024 |
17,000 |
16.00 |
272,000 |
| 07 Feb 2024 |
ETKIN AMIT |
PRESIDENT AND CEO |
06 Feb 2024 |
3,125 |
16.00 |
50,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock